Last updated: Nov 16, 2026, 12:00 AM

Aktis Oncology, Inc. Common stock Exchange (NASDAQ, USD)

AKTS

16.16
+1.08 (+6.60%)
HealthcareBiotechnology
Invest Today
Invest Today
1 year return (CAGR)
25828.68%
3 year return (CAGR)
87.20%
5 year return (CAGR)
17.59%
10 year return (CAGR)
-
Stock Analysis

Adobe 2026 Q3 – Is sentiment driving the price?

Read More
Marketcap
937.88M
Price/Sales
110.59
Ent value
928.15M
Price/Book
1.93
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-

Stock information

iO Charts Blog

What is a stock exchange? Operation, actors, examples

Read More

Stock chart

Loading...
Stock price data
Open16.22
Daily high17.62
Daily low16.21
Daily Volume464K
All-time high32.23
1y analyst estimate35.88
Beta-
EPS (TTM)-1.04
Dividend per share0.00
Ex-div date-
Next earnings date-

Ready to capitalize on Aktis Oncology, Inc. Common stock's growth potential?

Take the next step in your portfolio.

Invest Today

Downside potential

Loading...
Downside potential data
AKTSS&P500
Current price drop from All-time high-49.86%-5.02%
Highest price drop-99.97%-56.47%
Date of highest drop18 Dec 20249 Mar 2009
Avg drop from high-54.13%-10.64%
Avg time to new high64 days12 days
Max time to new high974 days1805 days